September 20, 2026

Chemotherapy and Targeted Therapy

The Silent Crisis: Why the Biopharma Industry is Losing Its Most Valuable Asset During Tech Transfer female technician in laboratory of genetics - reprogenetics

The Silent Crisis: Why the Biopharma Industry is Losing Its Most Valuable Asset During Tech Transfer

Sagoh June 23, 2026
In the high-stakes world of biopharmaceutical manufacturing, the term "technology transfer" often conjures images of seamless data...
Read More Read more about The Silent Crisis: Why the Biopharma Industry is Losing Its Most Valuable Asset During Tech Transfer
Pharma Industry Weekly: Leadership Shifts, Late-Stage Successes, and Strategic Funding Rounds pharma-industry-weekly-leadership-shifts-late-stage-successes-and-strategic-funding-rounds

Pharma Industry Weekly: Leadership Shifts, Late-Stage Successes, and Strategic Funding Rounds

Laily UPN June 22, 2026
The global pharmaceutical landscape is currently navigating a period of profound transition. From high-level C-suite departures at...
Read More Read more about Pharma Industry Weekly: Leadership Shifts, Late-Stage Successes, and Strategic Funding Rounds
Beyond the Initial Impact: The Convergence of TBI and Alzheimer’s Research and the Promise of Next-Generation Immunotherapy beyond-the-initial-impact-the-convergence-of-tbi-and-alzheimers-research-and-the-promise-of-next-generation-immunotherapy

Beyond the Initial Impact: The Convergence of TBI and Alzheimer’s Research and the Promise of Next-Generation Immunotherapy

Neng Nana June 22, 2026
Traumatic Brain Injury (TBI) is often perceived as a singular event—a collision, a fall, or a strike....
Read More Read more about Beyond the Initial Impact: The Convergence of TBI and Alzheimer’s Research and the Promise of Next-Generation Immunotherapy
Retatrutide’s Triple-Threat: Eli Lilly’s New Clinical Data Redefines the Obesity Treatment Paradigm retatrutides-triple-threat-eli-lillys-new-clinical-data-redefines-the-obesity-treatment-paradigm

Retatrutide’s Triple-Threat: Eli Lilly’s New Clinical Data Redefines the Obesity Treatment Paradigm

Muslim June 21, 2026
In the rapidly evolving landscape of metabolic medicine, Eli Lilly has achieved a decisive breakthrough that positions...
Read More Read more about Retatrutide’s Triple-Threat: Eli Lilly’s New Clinical Data Redefines the Obesity Treatment Paradigm
Shifting the Paradigm: How ADME-One is Moving Human PK Projections to the Start of the Drug Discovery Funnel shifting-the-paradigm-how-adme-one-is-moving-human-pk-projections-to-the-start-of-the-drug-discovery-funnel

Shifting the Paradigm: How ADME-One is Moving Human PK Projections to the Start of the Drug Discovery Funnel

Asep Darmawan June 21, 2026
In the traditional landscape of small-molecule drug discovery, the timeline is often dictated by a rigid, linear...
Read More Read more about Shifting the Paradigm: How ADME-One is Moving Human PK Projections to the Start of the Drug Discovery Funnel
Bridging the Gap: Bionews Unveils “The Rare Journey,” an Immersive Digital Leap for the Rare Disease Community bridging-the-gap-bionews-unveils-the-rare-journey-an-immersive-digital-leap-for-the-rare-disease-community

Bridging the Gap: Bionews Unveils “The Rare Journey,” an Immersive Digital Leap for the Rare Disease Community

Nana Muazin June 20, 2026
PENSACOLA, Florida — August 19, 2024 — For millions of individuals worldwide, the diagnosis of a rare...
Read More Read more about Bridging the Gap: Bionews Unveils “The Rare Journey,” an Immersive Digital Leap for the Rare Disease Community

You may have missed

mastering-the-gravity-defying-flow-the-art-of-the-ashtanga-jump-back

Mastering the Gravity-Defying Flow: The Art of the Ashtanga Jump-Back

Ammar Sabilarrohman September 20, 2026
cultivating-prosperity-the-bridges-engine-and-the-future-of-rural-agriculture-1

Cultivating Prosperity: The BRIDGES Engine and the Future of Rural Agriculture

Basiran September 20, 2026
a-lifesaving-breakthrough-for-brca-carriers-cambridge-study-confirms-bilateral-salpingo-oophorectomy-significantly-reduces-early-death-risk

A Lifesaving Breakthrough for BRCA Carriers: Cambridge Study Confirms Bilateral Salpingo-Oophorectomy Significantly Reduces Early Death Risk

Laily UPN September 20, 2026
the-pan-viral-frontier-can-cocrystal-pharma-rewrite-the-rules-of-antiviral-development-1

The Pan-Viral Frontier: Can Cocrystal Pharma Rewrite the Rules of Antiviral Development?

Rifan Muazin September 20, 2026